DLH Reports Fiscal 2023 Second Quarter Results
Revenue of
ATLANTA, May 03, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of research and development, systems engineering and integration, and digital transformation solutions to federal agencies, today announced financial results for its fiscal second quarter ended March 31, 2023.
Highlights
- Second quarter revenue was
$99.4 million in fiscal 2023 versus$108.7 million in fiscal 2022; the prior-year period included$39.8 million from the short-term FEMA task orders in Alaska. - Operating and net income for the second quarter were
$6.0 million and$0.8 million , respectively, as compared to$10.3 million and$7.2 million for the prior-year period. Operating income for the prior year period included$5.5 million from the FEMA task orders. - Earnings before interest, taxes, depreciation and amortization ("EBITDA") was
$10.5 million for the second quarter as compared to$12.1 million in fiscal 2022. The prior-year period included$5.5 million of EBITDA from the FEMA task orders. - Total debt at the end of the second quarter was
$204.2 million , compared to debt of$203.4 million as of December 31, 2022. The Company further reduced its outstanding debt balance to$196.3 million as of the date of this release. - Contract backlog was
$940.6 million as of March 31, 2023 versus$942.7 million at the end of the fiscal first quarter.
Management Discussion
"Strong second quarter results were in line with our expectations, as the Company completed its first full quarter following the acquisition of GRSi," said Zach Parker, DLH President and Chief Executive Officer. "Revenue for the quarter, which essentially reached the
"We announced an important award this quarter, gaining a seat on a highly coveted contract vehicle to provide technical solutions and support for the National Cancer Institute’s Center for Biomedical Informatics and Information Technology. This successful pursuit will allow DLH to contribute its expertise to the national imperative of scientific research for cancer causes and treatments. Such wins — and our significant pipeline of future opportunities — underscore the strength of our advanced, innovative offerings and the value that we have built through our growth strategy.
“In addition, we were pleased to welcome Judy Bjornaas, former Chief Financial Officer for ManTech, to the Company's Board of Directors at our annual meeting in March. Given her business acumen and experience within the industry, she has already made a positive impact on our organization — and we look forward to her playing a key role in our continued success. These recent developments, our solid backlog, and strong demand for our services position us well for the next chapter of our journey."
Results for the Three Months Ended March 31, 2023
Revenue for the second quarter of fiscal 2023 was
Income from operations was
Interest expense was
For the three months ended March 31, 2023 and 2022, respectively, DLH recorded a
On a non-GAAP basis, EBITDA for the three months ended March 31, 2023 was approximately
Key Financial Indicators
For fiscal 2023, DLH has produced
At March 31, 2023, total backlog was approximately
Conference Call and Webcast Details
DLH management will discuss second quarter results and provide a general business update, including current competitive conditions and strategies, during a conference call beginning at 10:00 AM Eastern Time tomorrow, May 4, 2023. Interested parties may listen to the conference call by dialing 888-347-5290 or 412-317-5256. Presentation materials will also be posted on the Investor Relations section of the DLH website prior to the commencement of the conference call.
A digital recording of the conference call will be available for replay two hours after the completion of the call and can be accessed on the DLH Investor Relations website or by dialing 877-344-7529 and entering the conference ID 9743329.
About DLH
DLH (NASDAQ:DLHC) enhances public health and national security readiness missions through science, technology, cyber, and engineering solutions and services. Our experts solve some of the most complex and critical missions faced by federal customers, leveraging digital transformation, artificial intelligence, advanced analytics, cloud-based applications, telehealth systems, and more. With over 3,200 employees dedicated to the idea that “Your Mission is Our Passion,” DLH brings a unique combination of government sector experience, proven methodology, and unwavering commitment to innovative solutions to improve the lives of millions. For more information, visit www.DLHcorp.com.
1 Adjusted Operating Income, EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue, and Adjusted EBITDA Margin on Adjusted Revenue are non-GAAP financial measures. See “Non-GAAP Financial Measures” below for additional detail.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:
This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements relate to future events or DLH`s future financial performance. Any statements that refer to expectations, projections or other characterizations of future events or circumstances or that are not statements of historical fact (including without limitation statements to the effect that the Company or its management “believes”, “expects”, “anticipates”, “plans”, “intends” and similar expressions) should be considered forward looking statements that involve risks and uncertainties which could cause actual events or DLH’s actual results to differ materially from those indicated by the forward-looking statements. Forward-looking statements in this release include, among others, statements regarding estimates of future revenues, operating income, earnings and cash flow. These statements reflect our belief and assumptions as to future events that may not prove to be accurate. Our actual results may differ materially from such forward-looking statements made in this release due to a variety of factors, including: the impact of the novel coronavirus (“COVID-19”), including the measures to reduce its spread, and its impact on the economy and demand for our services, are uncertain, cannot be predicted, and may precipitate or exacerbate other risks and uncertainties; the risk that we will not realize the anticipated benefits of our acquisition of GRSi or any other acquisitions (including anticipated future financial performance and results); the diversion of management’s attention from normal daily operations of the business and the challenges of managing larger and more widespread operations resulting from our recent acquisition; the inability to retain employees and customers; contract awards in connection with re-competes for present business and/or competition for new business; our ability to manage our increased debt obligations; compliance with bank financial and other covenants; changes in client budgetary priorities; government contract procurement (such as bid and award protests, small business set asides, loss of work due to organizational conflicts of interest, etc.) and termination risks; the ability to successfully integrate the operations of GRSi or any future acquisitions; the impact of inflation and higher interest rates; and other risks described in our SEC filings. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see “Risk Factors” in the Company’s periodic reports filed with the SEC, including our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, as well as subsequent reports filed thereafter. The forward-looking statements contained herein are not historical facts, but rather are based on current expectations, estimates, assumptions and projections about our industry and business.
Such forward-looking statements are made as of the date hereof and may become outdated over time. The Company does not assume any responsibility for updating forward-looking statements, except as may be required by law.
CONTACTS:
| INVESTOR RELATIONS |
| Contact: Chris Witty |
| Phone: 646-438-9385 |
| Email: cwitty@darrowir.com |
TABLES TO FOLLOW
| DLH HOLDINGS CORP. | ||||||||||||
| CONSOLIDATED STATEMENTS OF INCOME | ||||||||||||
| (Amounts in thousands except per share amounts) | ||||||||||||
| (unaudited) | (unaudited) | |||||||||||
| Three Months Ended | Six Months Ended | |||||||||||
| March 31, | March 31, | |||||||||||
| 2023 | 2022 | 2023 | 2022 | |||||||||
| Revenue | $ | 99,417 | $ | 108,699 | $ | 172,155 | $ | 261,500 | ||||
| Cost of Operations: | ||||||||||||
| Contract costs | 78,238 | 88,831 | 135,494 | 221,517 | ||||||||
| General and administrative costs | 10,693 | 7,733 | 18,117 | 14,644 | ||||||||
| Corporate development costs | — | — | 1,735 | — | ||||||||
| Depreciation and amortization | 4,535 | 1,881 | 6,937 | 3,866 | ||||||||
| Total operating costs | 93,466 | 98,445 | 162,283 | 240,027 | ||||||||
| Income from operations | 5,951 | 10,254 | 9,872 | 21,473 | ||||||||
| Interest expense | 4,765 | 554 | 6,595 | 1,226 | ||||||||
| Income before provision for income taxes | 1,186 | 9,700 | 3,277 | 20,247 | ||||||||
| Provision for income taxes | 381 | 2,522 | 925 | 5,265 | ||||||||
| Net income | $ | 805 | $ | 7,178 | $ | 2,352 | $ | 14,982 | ||||
| Net income per share - basic | $ | 0.06 | $ | 0.56 | $ | 0.17 | $ | 1.17 | ||||
| Net income per share - diluted | $ | 0.06 | $ | 0.50 | $ | 0.16 | $ | 1.04 | ||||
| Weighted average common shares outstanding | ||||||||||||
| Basic | 13,759 | 12,778 | 13,530 | 12,763 | ||||||||
| Diluted | 14,600 | 14,442 | 14,447 | 14,368 | ||||||||
| DLH HOLDINGS CORP. | ||||||
| CONSOLIDATED BALANCE SHEETS | ||||||
| (Amounts in thousands except par value of shares) | ||||||
| March 31, 2023 | September 30, 2022 | |||||
| (unaudited) | ||||||
| ASSETS | ||||||
| Current assets: | ||||||
| Cash | $ | 137 | $ | 228 | ||
| Accounts receivable | 67,021 | 40,496 | ||||
| Other current assets | 3,513 | 2,878 | ||||
| Total current assets | 70,671 | 43,602 | ||||
| Equipment and improvements, net | 1,558 | 1,704 | ||||
| Operating lease right-of-use assets | 18,754 | 16,851 | ||||
| Goodwill | 138,301 | 65,643 | ||||
| Intangible assets, net | 133,109 | 40,884 | ||||
| Other long-term assets | 183 | 328 | ||||
| Total assets | $ | 362,576 | $ | 169,012 | ||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||
| Current liabilities: | ||||||
| Operating lease liabilities - current | $ | 3,452 | $ | 2,235 | ||
| Accrued payroll | 17,279 | 9,444 | ||||
| Debt obligations - current, net of deferred financing costs | 33,267 | — | ||||
| Accounts payable and accrued liabilities | 25,066 | 26,862 | ||||
| Total current liabilities | 79,064 | 38,541 | ||||
| Long-term liabilities: | ||||||
| Deferred taxes, net | 1,203 | 1,534 | ||||
| Operating lease liabilities - long-term | 17,337 | 16,461 | ||||
| Debt obligations - long-term, net of deferred financing costs | 162,636 | 20,416 | ||||
| Other long-term liabilities | 396 | — | ||||
| Total long-term liabilities | 181,572 | 38,411 | ||||
| Total liabilities | 260,636 | 76,952 | ||||
| Shareholders' equity: | ||||||
| Common stock, | 14 | 13 | ||||
| Additional paid-in capital | 98,584 | 91,057 | ||||
| Retained earnings | 3,342 | 990 | ||||
| Total shareholders’ equity | 101,940 | 92,060 | ||||
| Total liabilities and shareholders' equity | $ | 362,576 | $ | 169,012 | ||
| DLH HOLDINGS CORP. | ||||||||
| CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||||
| (Amounts in thousands) | ||||||||
| (unaudited) | ||||||||
| Six Months Ended | ||||||||
| March 31, | ||||||||
| 2023 | 2022 | |||||||
| Operating activities | ||||||||
| Net income | $ | 2,352 | $ | 14,982 | ||||
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||||||||
| Depreciation and amortization | 6,937 | 3,866 | ||||||
| Amortization of deferred financing costs charged to interest expense | 904 | 319 | ||||||
| Stock-based compensation expense | 1,352 | 1,309 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (1,057 | ) | (28,705 | ) | ||||
| Other current assets | 719 | 666 | ||||||
| Accrued payroll | 8 | 3,339 | ||||||
| Deferred revenue | — | (22,273 | ) | |||||
| Accounts payable and accrued liabilities | (4,757 | ) | 11,600 | |||||
| Other long-term assets and liabilities | 404 | 82 | ||||||
| Net cash provided by (used in) operating activities | 6,862 | (14,815 | ) | |||||
| Investing activities | ||||||||
| Business acquisition, net of cash acquired | (180,711 | ) | — | |||||
| Purchase of equipment and improvements | (463 | ) | (89 | ) | ||||
| Net cash used in investing activities | (181,174 | ) | (89 | ) | ||||
| Financing activities | ||||||||
| Proceeds from revolving line of credit | 32,594 | 13,500 | ||||||
| Repayment of revolving line of credit | (11,264 | ) | (13,500 | ) | ||||
| Proceeds from debt obligations | 168,000 | — | ||||||
| Repayments of debt obligations | (7,125 | ) | (9,250 | ) | ||||
| Payments of deferred financing costs | (7,622 | ) | — | |||||
| Proceeds from issuance of common stock upon exercise of options and warrants | 287 | 462 | ||||||
| Payment of tax obligations resulting from net exercise of stock options | (649 | ) | — | |||||
| Net cash provided by (used in) financing activities | 174,221 | (8,788 | ) | |||||
| Net change in cash | (91 | ) | (23,692 | ) | ||||
| Cash - beginning of period | 228 | 24,051 | ||||||
| Cash - end of period | $ | 137 | $ | 359 | ||||
| Supplemental disclosure of cash flow information | ||||||||
| Cash paid during the period for interest | $ | 5,714 | $ | 896 | ||||
| Cash paid during the period for income taxes | $ | 3,202 | $ | 3,482 | ||||
| Supplemental disclosure of non-cash activity | ||||||||
| Common stock surrendered for the exercise of stock options | $ | 238 | $ | — | ||||
Non-GAAP Financial Measures
The Company uses EBITDA and EBITDA Margin on Revenue as supplemental non-GAAP measures of performance. We define EBITDA as net income excluding (i) interest expense, (ii) provision for or benefit from income taxes and (iii) depreciation and amortization. EBITDA Margin on Revenue is EBITDA for the measurement period divided by revenue for the same period.
The Company is presenting additional non-GAAP measures regarding its financial performance for the three and six months ended March 31, 2023. The measures presented are Adjusted Revenue, Adjusted Operating Income, Adjusted EBITDA, and Adjusted EBITDA Margin on Adjusted Revenue. In calculating these measures, we have added the corporate development costs associated with completing the GRSi acquisition to our results for fiscal year 2023 and we have removed the contribution from the FEMA task orders from the results for fiscal year 2022. These resulting measures present the quarterly financial performance compared to results delivered in the prior year period. Definitions of these additional non-GAAP measures are set forth below.
We have prepared these additional non-GAAP measures to eliminate the impact of items that we do not consider indicative of ongoing operating performance due to their inherent unusual or extraordinary nature. These non-GAAP measures of performance are used by management to conduct and evaluate its business during its review of operating results for the periods presented. Management and the Company's Board utilize these non-GAAP measures to make decisions about the use of the Company's resources, analyze performance between periods, develop internal projections and measure management performance. We believe that these non-GAAP measures are useful to investors in evaluating the Company's ongoing operating and financial results and understanding how such results compare with the Company's historical performance.
These supplemental performance measurements may vary from and may not be comparable to similarly titled measures by other companies in our industry. Further, the additional non-GAAP financial measures we presented for the first quarter of fiscal 2023 excluded the contribution from GRSi due to the truncated consolidation period. Since GRSi was part of the consolidated financial performance for the full second quarter, we have included their results in both the three and six month periods ended March 31, 2023. Adjusted Revenue, Adjusted Operating Income, EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue, and Adjusted EBITDA Margin on Adjusted Revenue are not recognized measurements under accounting principles generally accepted in the United States, or GAAP, and when analyzing our performance investors should (i) evaluate each adjustment in our reconciliation to the nearest GAAP financial measures and (ii) use the aforementioned non-GAAP measures in addition to, and not as an alternative to, revenue, operating income, net income or diluted EPS, as measures of operating results, each as defined under GAAP. We have defined these non-GAAP measures as follows:
“Adjusted Revenue” represents revenue less the contribution to revenue from the short-term FEMA task orders
“Adjusted Operating Income” represents operating income plus the corporate development costs associated with completing the GRSi acquisition incurred in fiscal 2023 less the contribution from the FEMA task orders, which occurred in fiscal 2022.
“Adjusted EBITDA” represents net income before income taxes, interest, depreciation and amortization and the corporate costs associated with completing the acquisition, less the contribution from FEMA task orders. “Adjusted EBITDA Margin on Adjusted Revenue” is calculated as Adjusted EBITDA divided by Adjusted Revenue.
Below is a reconciliation of Adjusted Revenue, Adjusted Operating Income, EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue and Adjusted EBITDA Margin on Adjusted Revenue reported for the three and six months ended March 31, 2023 and 2022 compared to the most directly comparable financial measure calculated and presented in accordance with GAAP (in thousands except for per share amounts):
| Three Months Ended | Six Months Ended | |||||||||||||||||||||||
| March 31, | March 31, | |||||||||||||||||||||||
| 2023 | 2022 | Change | 2023 | 2022 | Change | |||||||||||||||||||
| Adjusted Revenue | ||||||||||||||||||||||||
| Revenue | $ | 99,417 | $ | 108,699 | $ | (9,282 | ) | $ | 172,155 | $ | 261,500 | $ | (89,345 | ) | ||||||||||
| Less: FEMA task orders to support Alaska (a) | — | 39,764 | (39,764 | ) | — | 130,889 | (130,889 | ) | ||||||||||||||||
| Adjusted Revenue | $ | 99,417 | $ | 68,935 | $ | 30,482 | $ | 172,155 | $ | 130,611 | $ | 41,544 | ||||||||||||
| Adjusted Operating Income | ||||||||||||||||||||||||
| Operating Income | $ | 5,951 | $ | 10,254 | $ | (4,303 | ) | $ | 9,872 | $ | 21,473 | $ | (11,601 | ) | ||||||||||
| Corporate development costs (b) | — | — | — | 1,735 | — | 1,735 | ||||||||||||||||||
| Less: FEMA task orders to support Alaska (c) | — | 5,525 | (5,525 | ) | — | 11,871 | (11,871 | ) | ||||||||||||||||
| Adjusted Operating Income | $ | 5,951 | $ | 4,729 | $ | 1,222 | $ | 11,607 | $ | 9,602 | $ | 2,005 | ||||||||||||
| EBITDA, Adjusted EBITDA, EBITDA Margin on Revenue & Adjusted EBITDA Margin on Adjusted Revenue | ||||||||||||||||||||||||
| Net Income | $ | 805 | $ | 7,178 | $ | (6,373 | ) | $ | 2,352 | $ | 14,982 | $ | (12,630 | ) | ||||||||||
| Depreciation and amortization | 4,535 | 1,881 | 2,654 | 6,937 | 3,866 | 3,071 | ||||||||||||||||||
| Interest expense | 4,765 | 554 | 4,211 | 6,595 | 1,226 | 5,369 | ||||||||||||||||||
| Provision for income taxes | 381 | 2,522 | (2,141 | ) | 925 | 5,265 | (4,340 | ) | ||||||||||||||||
| EBITDA | $ | 10,486 | $ | 12,135 | $ | (1,649 | ) | $ | 16,808 | $ | 25,339 | $ | (8,531 | ) | ||||||||||
| Corporate development costs (b) | $ | — | $ | — | $ | — | $ | 1,735 | $ | — | $ | 1,735 | ||||||||||||
| Less: acquired EBITDA | — | — | — | — | — | — | ||||||||||||||||||
| Less: FEMA task order to support Alaska (c) | — | 5,525 | (5,525 | ) | — | 11,871 | (11,871 | ) | ||||||||||||||||
| Adjusted EBITDA | $ | 10,486 | $ | 6,610 | $ | 3,876 | $ | 18,543 | $ | 13,468 | $ | 5,075 | ||||||||||||
| Net income margin on Revenue | 0.8 | % | 6.6 | % | 1.4 | % | 5.7 | % | ||||||||||||||||
| EBITDA Margin on Revenue | 10.5 | % | 11.2 | % | 9.8 | % | 9.7 | % | ||||||||||||||||
| Adjusted EBITDA Margin on Adjusted Revenue | 10.5 | % | 9.6 | % | 10.8 | % | 10.3 | % | ||||||||||||||||
(a): Represents revenue adjusted to exclude revenue from the short-term FEMA task orders during the three and six months ended March 31, 2022.
(b): Represents corporate development costs we incurred to complete the GRSi transaction. These costs primarily include legal counsel, financial due diligence, customer market analysis and representation and warranty insurance premiums.
(c): Adjusted operating income represents the Company’s consolidated operating income, determined in accordance with GAAP, adjusted to add the corporate development costs associated with the GRSi acquisition for fiscal year 2023 and adjusted to exclude the operating income derived from the FEMA task orders. Operating income for the FEMA task orders is derived by subtracting from the revenue attributable to such task orders during the three months ended March 31, 2022 of
